Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

661
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
661
CRISPR and crRNAs02:53

CRISPR and crRNAs

17.8K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.8K
CRISPR01:59

CRISPR

53.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.5K
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

283
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
283
Homologous Recombination02:31

Homologous Recombination

55.7K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
55.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Prime Editing Efficiency in Human Immortalized MSC-TERT Cells with Osteogenic Potential for Modeling <i>FGFR2</i>-Linked Craniosynostosis.

The CRISPR journal·2026
Same author

Molecular basis for methylation-sensitive editing by Cas9.

Nature·2026
Same author

Deletion of the <i>moe</i>A gene in <i>Flavobacterium</i> IR1 drives structural color shift from green to blue and alters polysaccharide metabolism.

eLife·2026
Same author

An updated evolutionary classification of CRISPR-Cas systems including rare variants.

Nature microbiology·2025
Same author

Targeted DNA ADP-ribosylation triggers templated repair in bacteria and base mutagenesis in eukaryotes.

Nature biotechnology·2025
Same author

<i>Pseudosulfitobacter pseudonitzschiae</i> hitchhikes on gliding colonies of <i>Cellulophaga lytica</i>.

ISME communications·2025
Same journal

Correction to 'scSuperAnnotator: A platform for benchmarking comparison and visualizing automated cellular annotation methods for scRNA-seq data'.

Nucleic acids research·2026
Same journal

Correction to 'Differentiable partition function calculation for RNA'.

Nucleic acids research·2026
Same journal

Deployment of non-canonical splicing in tunicate genomes is mediated by divergent U2AF function and changing m6A modification in U1 and U6 snRNA.

Nucleic acids research·2026
Same journal

Bacillus subtilis DnaB forms multiple protein-protein interactions essential for DNA replication initiation.

Nucleic acids research·2026
Same journal

Multiple forms of protein-protein and DNA binding are exhibited by BrxC from the BREX phage restriction system.

Nucleic acids research·2026
Same journal

Biosynthesis of glycosylated 5-hydroxycytosine in the DNA of diverse viruses.

Nucleic acids research·2026
See all related articles

Related Experiment Video

Updated: Oct 17, 2025

Genome Editing in Mammalian Cell Lines using CRISPR-Cas
07:56

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

22.3K

Streamlined CRISPR genome engineering in wild-type bacteria using SIBR-Cas.

Constantinos Patinios1, Sjoerd C A Creutzburg1, Adini Q Arifah1

  • 1Laboratory of Microbiology, Wageningen University and Research, Stippeneng 4, 6708 WE, Wageningen, The Netherlands.

Nucleic Acids Research
|October 6, 2021
PubMed
Summary
This summary is machine-generated.

We developed SIBR-Cas, a novel genome engineering tool for bacteria. This system overcomes limitations of CRISPR-Cas by providing inducible control, enabling efficient gene editing in diverse bacterial species without recombinases.

More Related Videos

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

34.6K
Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins
10:46

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins

Published on: October 18, 2022

1.9K

Related Experiment Videos

Last Updated: Oct 17, 2025

Genome Editing in Mammalian Cell Lines using CRISPR-Cas
07:56

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

22.3K
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

34.6K
Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins
10:46

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins

Published on: October 18, 2022

1.9K

Area of Science:

  • Microbiology
  • Molecular Biology
  • Synthetic Biology

Background:

  • CRISPR-Cas systems are powerful for bacterial genome editing but often require host factors or exogenous recombinases.
  • Existing methods face limitations in efficiency and applicability across different bacterial species, especially those with less efficient homologous recombination.

Purpose of the Study:

  • To develop a simple, widely applicable genome engineering tool for bacteria that mitigates constraints of existing CRISPR-Cas systems.
  • To enable efficient gene editing in bacteria, including those with poor homologous recombination systems, without relying on exogenous recombinases.

Main Methods:

  • Engineered a Self-splicing Intron-Based Riboswitch-Cas (SIBR-Cas) system using a mutant T4 td intron library for inducible control.
  • SIBR-Cas provides delayed CRISPR-Cas counter-selection to allow time for homologous recombination-mediated editing.
  • Applied SIBR-Cas to knock out genes in wild-type Escherichia coli, Pseudomonas putida, and Flavobacterium species.

Main Results:

  • Successfully achieved gene knockouts in three distinct bacterial species (E. coli, P. putida, F. IR1) using SIBR-Cas.
  • Demonstrated efficient genome editing without the need for exogenous recombinases, even in bacteria with poor native homologous recombination.
  • SIBR-Cas offers tight and inducible control over CRISPR-Cas counter-selection, enhancing editing efficiency.

Conclusions:

  • SIBR-Cas is a simple, tightly regulated, and broadly applicable genome engineering tool for diverse bacterial species, particularly non-model organisms.
  • The SIBR system shows potential for broader applications in bacterial gene expression and regulation control.
  • This approach overcomes key limitations of current bacterial genome editing technologies.